Mostrar el registro sencillo del ítem

dc.contributor.authorKissling, E
dc.contributor.authorValenciano, M
dc.contributor.authorI-MOVE Case-Control Studies Team
dc.contributor.authorJimenez-Jorge, Silvia
dc.contributor.authorMateo-Ontañon, Salvador de 
dc.contributor.authorPozo Sanchez, Francisco 
dc.contributor.authorLedesma, Juan 
dc.contributor.authorCasas Flecha, Inmaculada 
dc.contributor.authorLarrauri, Amparo 
dc.date.accessioned2023-02-10T10:26:24Z
dc.date.available2023-02-10T10:26:24Z
dc.date.issued2011-03-17
dc.identifier.citationEuro Surveill. 2011 Mar 17;16(11):19818.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15490
dc.description.abstractWe present early estimates (up to week 4 of 2011) of the 2010/11 seasonal influenza vaccine effectiveness in preventing medically attended influenza-like illness(ILI) laboratory confirmed as influenza. Practitioners from seven European sentinel networks systematically swabbed ILI patients. We included patients meeting the European Union ILI case definition and swabbed less than eight days after symptom onset. Laboratory-confirmed influenza cases were compared with negative controls. The adjusted vaccine effectiveness was 42.3% (95% CI: -7.3 to 69.0%), suggesting moderate protection of the seasonal vaccine.es_ES
dc.description.sponsorshipThe I-MOVE network has been funded by the European Centre for Disease Prevention and Control (ECDC) since 2007.es_ES
dc.language.isoenges_ES
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshDisease Outbreaks es_ES
dc.subject.meshAdolescent es_ES
dc.subject.meshAdult es_ES
dc.subject.meshAged es_ES
dc.subject.meshCase-Control Studies es_ES
dc.subject.meshChild es_ES
dc.subject.meshEurope es_ES
dc.subject.meshEuropean Union es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInfant es_ES
dc.subject.meshInfant, Newborn es_ES
dc.subject.meshInfluenza A Virus, H1N1 Subtype es_ES
dc.subject.meshInfluenza Vaccines es_ES
dc.subject.meshInfluenza, Humanes_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshSentinel Surveillance es_ES
dc.subject.meshTreatment Outcome es_ES
dc.subject.meshVaccination es_ES
dc.subject.meshYoung Adult es_ES
dc.titleEarly estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control studyes_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID21435329es_ES
dc.format.volume16es_ES
dc.format.number11es_ES
dc.format.page19818es_ES
dc.identifier.doi10.2807/ese.16.11.19818-enes_ES
dc.contributor.funderUnión Europea. European Centre for Disease Prevention and Control (ECDC) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1560-7917es_ES
dc.relation.publisherversionhttp://dx.doi.org/10.2807/ese.16.11.19818-enes_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional